Northern Trust’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Northern Trust’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	+38,882	New	+$999K	﹤0.01%	3339
2024 Q3	–	Sell	-1,426	Closed	-$16.9K	–	4426
2024 Q2	$16.9K	Buy	1,426 +604	+73%	+$9.54K	﹤0.01%	4343
2024 Q1	$16K	Hold	822	–	–	﹤0.01%	4358
2023 Q4	$14.8K	Hold	822	–	–	﹤0.01%	4393
2023 Q3	$14.8K	Hold	822	–	–	﹤0.01%	4369
2023 Q2	$51.8K	Hold	822	–	–	﹤0.01%	4217
2023 Q1	$40.9K	Hold	822	–	–	﹤0.01%	4303
2022 Q4	$23.6K	Hold	822	–	–	﹤0.01%	4458
2022 Q3	$39K	Hold	822	–	–	﹤0.01%	4389
2022 Q2	$36K	Buy	822 +62	+8%	+$2.84K	﹤0.01%	4499
2022 Q1	$42K	Hold	760	–	–	﹤0.01%	4570
2021 Q4	$58K	Hold	760	–	–	﹤0.01%	4565
2021 Q3	$68K	Buy	+760	New	+$81.3K	﹤0.01%	4484

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Northern Trust's DMRA Position: Q1 2026 in Review

Northern Trust opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 38,882 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #3339 among its holdings. This is a return to the name: Northern Trust previously reported a position in DMRA as recently as Q2 2024.

Northern Trust first reported a position in DMRA in Q3 2021 and has held it in 13 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

Northern Trust held 38,882 shares of Damora Therapeutics, Inc. Ordinary Shares worth $1.01M as of Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares was a new Northern Trust position in Q1 2026.
Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3339 holding.
Northern Trust first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2021 and has held it in 13 quarters since.
65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.